Diebold Inc. Stock
Price
Target price
-
-
-
-
-
?27.12
WKN: 856244 / Symbol: DBD / Name: Diebold / Stock / Computers, Phones & Household Electronics / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Diebold Inc. Stock
Our community is currently low on Diebold Inc. with 1 Buy predictions and 4 Sell predictions.
On the other hand, the target price of 27 € is above the current price of 0.22 € for Diebold Inc., so the potential is actually 12117.19%.
Pros and Cons of Diebold Inc. in the next few years
Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Diebold Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Diebold Inc. | - | - | - | - | - | - | - |
| Key Tronic Corp. | -0.480% | -2.358% | -10.390% | -33.226% | 10.106% | -36.794% | -11.652% |
| Synaptics Inc. | -2.720% | -9.817% | -15.044% | -15.882% | -27.547% | -30.277% | - |
| Wayside Technology Group | 0.820% | -2.381% | 1.653% | 30.297% | 23.992% | 195.673% | 489.645% |
Comments
Diebold Nixdorf, Incorporated (NYSE: DBD) was upgraded by analysts at DA Davidson from a "neutral" rating to a "buy" rating. They now have a $29.00 price target on the stock, up previously from $25.00.
Show more
Ratings data for DBD provided by MarketBeat
Diebold Nixdorf, Incorporated (NYSE: DBD) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for DBD provided by MarketBeat
Diebold Nixdorf, Incorporated (NYSE: DBD) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for DBD provided by MarketBeat